Hong Kong’s private healthcare providers expected to offer RSV vaccine from mid-December, but experts say more data needed to decide if public sector should follow suit

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

British pharmaceutical company GSK beats Pfizer in race to offer vaccine that can protect elderly against common respiratory infection.